Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Determinants of Physical Activity Levels in Postmenopausal Women: A CHAID-Based Analysis

NCT07936916 is registered in ClinicalTrials.gov with Ondokuz Mayıs University as lead sponsor.

NCT NCT07936916 Not yet recruiting Observational 385 participants (estimated) Started 2026 1 site

Follow this trial by email Email me the PDF

Get the NCT07936916 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Summary

Not yet recruiting, started November 2026. Observational study, 385 participants (estimated). Lead sponsor Ondokuz Mayıs University; Turkey (Türkiye). Primary measures: Anthropometric Assessment; International Physical Activity Questionnaire Short Form (IPAQ-SF) and 5 more.

Registry record

As filed in ClinicalTrials.gov.

Title
Determinants of Physical Activity Levels in Postmenopausal Women: A CHAID-Based Analysis
Lead sponsor
Ondokuz Mayıs University
Phase
Observational
Overall status
Not yet recruiting
Start date
November 15, 2026
Completion date
February 28, 2027
Enrollment
385 (estimated)
Sites
1

Conditions

As the registry lists them.

physical activity, postmenopause

Who could take part, where it ran, who ran it

As filed in ClinicalTrials.gov.

Sex
Female
Minimum age
45 Years
Maximum age
64 Years
Healthy volunteers
Yes
Study type
Observational
Sites
1
Countries
Turkey (Türkiye)
Lead sponsor
Ondokuz Mayıs University

Arms

As registered; 1 arm.

Registered arms
Arm Type Interventions
Postmenopausal women
Show registry wording

Postmenopausal women aged 45-64 years

Primary endpoints

Registered primary outcome measures; 7 primary.

Registered primary endpoints
Measure Time frame
Anthropometric Assessment Baseline
Show registry wording

Participants' height, body weight, and waist circumference will be measured. Body mass index will be calculated by dividing body weight by the square of height in meters, and waist-to-height ratio will be calculated by dividing waist circumference by height.

International Physical Activity Questionnaire Short Form (IPAQ-SF) Baseline
Show registry wording

The multinational validity and reliability findings of this questionnaire, developed by an international working group, were published by Craig et al. The Turkish validity and reliability study was conducted by Sağlam et al. The questionnaire provides information about walking, moderate-intensity and vigorous-intensity physical activity, and time spent sitting over the last seven days.

Body Cathexis Scale ( BCS) Baseline
Show registry wording

The scale, developed by Secord and Jourard, assesses an individual's satisfaction with different parts of the body and bodily functions. The Turkish validity and reliability study was conducted by Hovardaoğlu. The Turkish form consists of 40 items rated on a five-point Likert scale. The total score ranges from 40 to 200, with higher scores indicating decreased satisfaction with the body.

Menopause Rating Scale (MRS) Baseline
Show registry wording

The international versions and psychometric properties of this scale, developed to assess the severity of menopause-related complaints, were published by Heinemann et al. The Turkish validity and reliability study was conducted by Can Gürkan. The scale consists of 11 items assessing somatic, psychological, and urogenital complaints. Each item is scored from 0 to 4, and the total score ranges from 0 to 44. Higher scores indicate a greater burden of menopausal symptoms.

Rosenberg Self-Esteem Scale Baseline
Show registry wording

The Turkish adaptation and validity and reliability study of the scale, developed by Rosenberg, was conducted by Çuhadaroğlu. In this study, the 10-item section of the scale assessing self-esteem will be used. The original scoring key of the Turkish adaptation will be followed; the direction and score range of the total score to be used will be finalized before data analysis.

+2 more primary endpoints

Lead sponsor's other trials

Ondokuz Mayıs University, most recent start first.